Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
PTI NDQ TLB OMG Natural Foods Small Growth Farming Manufacturing 
United States  USA  |  Company Directory


Processing
Processing. Please wait...

Immunotec insider: Patrick Montpetit

       

Patrick Montpetit - Immunotec Insider Profile

CFO, Vice President

Mr. Patrick Montpetit is Chief Financial Officer, Vice President of Immunotec Inc. Prior to joining the Company, Mr. Montpetit held a number of senior financial management positions, most recently as VicePresident, Finance and Chief Financial Officer of Bioniche Life Sciences Inc . His experience over the past fifteen years was in the life sciences and biopharmaceutical industries where he was involved in raising over 250 million dollars in growth capital. During this time, he served as Chairman of the Quebec Biotechnology Association and as a director of the Montreal InVivo organization. Prior to Bioniche, Mr. Montpetit was the Director of Finance, Administration, Commercial Agreements and Alliances with DSM Biologics Inc., a multinational pharmaceutical company and the Netherlands. Mr. Montpetit is a Chartered Accountant combined with a specialty in corporate finance from the Canadian Institute of Chartered Accountants.
  President Since 2009      
450-424-9992  http://www.immunotec.com

Other Appointments

Immunotec IncIMMTFUnited States OTC
President since 2009
IMMTECH PHARM INCIMMUnited States AMEX
President since 2009
Immunotec IncIMMTFUnited States OTC
President since 2009

Management Efficency

The company has return on total asset (ROA) of 4.83 % which means that it generated profit of $4.83 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 5.35 % meaning that it generated $5.35 on every $100 dollars invested by stockholders.
The company has accumulated 2.05 M in total debt with debt to equity ratio (D/E) of 0.17 which may suggest the company is not taking enough advantage from borrowing. Immunotec Inc has Current Ratio of 1.39 which is within standard range for the sector.
    

Other Executives

Robert Henry, Chairman
Rod Milne, President
Daniel Audet, President
J Trottier, President
Stuart MacMillan, President
John Molson, President
Patrick CA,CF, CFO
Robert Felton, COO
Charles Roberts, Director
Robert Depatie, Director
Roderick Budd, Director
Dieter Beer, Director
Charles Orr, Director

Entity Summary

Immunotec Inc., a network marketing company, manufactures and sells natural health solutions and dietary supplements in Canada, the United States, Europe, Mexico, and the Caribbean. Immunotec Inc [IMM] is traded on TSX Venture Exchange in Canada. It is located in VaudreuilDorion, QC JV V and employs 13 people. Filter other
    
Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 
    
    
IMM Canada TSXV #B1P77Y5CA
Immunotec Inc
Currency: CAD - Canadian Dollar
Traded on TSX Venture Exchange
    
    
Chance of
Bankruptcy
Less
Than
16%
In The Next
Two Years
Immunotec Inc has less than 16.16 (%) percent chance of experiencing financial distress in the next 2 years of operations.
    
    

Immunotec price boundaries

    
April 22 2013
 0.18 
  
 0.18 
0.00  No Change   0.00%  
Lowest period price (30 days)
May 17 2013
 0.19 
  
 0.20 
0.01  Macroaxis: 5.263157894736847 Up   5.26%  
Highest period price (30 days)
    

Promote Immunotec and Patrick Montpetit

Follow Immunotec with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Immunotec to your reader
 

Today Change

 thisGreen IMM IMM.V agains markets  8.33 % Macroaxis: change 8.33 Moved Up  
 
 Canada Canada   0.84 % Macroaxis: 0.84 Moved Up  
 

Stock Performance

Shares Outstanding69.77 M


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium